YARROW BIOSCIENCE, INC. Depreciation
YARROW BIOSCIENCE, INC. (YARW) reported Depreciation of $6.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-13
- YARROW BIOSCIENCE, INC. depreciation for the quarter ending 2026-06-30 was $6.00K, a 50.00% decline year-over-year.
- YARROW BIOSCIENCE, INC. depreciation for the quarter ending 2026-03-31 was $6.00K, a 0.00% change year-over-year.
- YARROW BIOSCIENCE, INC. depreciation for the quarter ending 2025-06-30 was $12.00K.
- YARROW BIOSCIENCE, INC. depreciation for the quarter ending 2025-03-31 was $6.00K.
- YARROW BIOSCIENCE, INC. depreciation for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- YARROW BIOSCIENCE, INC. depreciation for fiscal 2022 was $100.00K.
| Period end | Depreciation 3 month | Depreciation 3 month as first filed | Depreciation 6 month | Depreciation 12 month |
|---|---|---|---|---|
| 2026-06-30 | $6.00K 10-Q · filed 2026-08-13 | $6.00K 10-Q · filed 2026-08-13 | ||
| 2026-03-31 | $6.00K S-4/A · filed 2026-06-03 | |||
| 2025-12-31 | $23.00K S-4/A · filed 2026-06-03 | |||
| 2025-06-30 | $12.00K 10-Q · filed 2026-08-13 | $6.00K 10-Q · filed 2025-08-14 | $12.00K 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $6.00K S-4/A · filed 2026-06-03 | |||
| 2024-12-31 | $4.00K S-4/A · filed 2026-06-03 | |||
| 2024-06-30 | $0.00 10-Q · filed 2025-08-14 | $0.00 10-Q · filed 2025-08-14 | ||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | $0.00 10-K · filed 2025-03-06 | |||
| 2022-12-31 | $100.00K 10-K · filed 2024-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |